Drug · DIN 02455927
EMPLICITI
300 MG WHEN RECONSTITUTED, SINGLE-USE VIAL
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since December 12, 2023.
- Drug Identification Number (DIN)
- 02455927
- Company (DIN owner)
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Elotuzumab L01FX08
- Class
- Human
- Record last updated
- August 27, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELOTUZUMAB | 340 MG | VIAL |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 21, 2016: NOC 18195New Drug Submission (NDS)
Other DINs named EMPLICITI
- DIN 02455919 · Cancelled Pre Market